Compare · APGB vs BLAC
APGB vs BLAC
Side-by-side comparison of Apollo Strategic Growth Capital II (APGB) and Bellevue Life Sciences Acquisition Corp. (BLAC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APGB and BLAC operate in Blank Checks (Finance), so they compete in similar markets.
- APGB carries a market cap of $836.6M.
APGB
Apollo Strategic Growth Capital II
Apollo Strategic Growth Capital II intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as APH I (Sub I), Ltd. and changed its name to Apollo Strategic Growth Capital II in December 2020. Apollo Strategic Growth Capital II was incorporated in 2008 and is based in New York, New York.
Latest APGB
- SEC Form SC 13G/A filed by Apollo Strategic Growth Capital II (Amendment)
- SEC Form SC 13G/A filed by Apollo Strategic Growth Capital II (Amendment)
- SEC Form SC 13G filed by Apollo Strategic Growth Capital II
- SEC Form 15-12G filed by Apollo Strategic Growth Capital II
- SEC Form 25-NSE filed by Apollo Strategic Growth Capital II
- SEC Form 10-Q filed by Apollo Strategic Growth Capital II
- Apollo Strategic Growth Capital II filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Apollo Strategic Growth Capital II Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination; Per-Share Redemption Price For The Public Shares Will Be ~$10.58
- Apollo Strategic Growth Capital II Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination
- SEC Form 10-Q filed by Apollo Strategic Growth Capital II
Latest BLAC
- OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG
- OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token
- SEC Form 3 filed by new insider Kim Sang Harry
- SEC Form 3 filed by new insider Cho Joong Myung
- SEC Form 3 filed by new insider Barberis Alcide
- Bellevue Life Sciences Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Leadership Update, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Financial Statements and Exhibits
- SEC Form 3 filed by new insider Bang Gihyoun
- SEC Form 3 filed by new insider Jee Hyuk Joo
- Large owner Bellevue Global Life Science Investors Llc acquired 43,000 shares, increasing direct ownership by 2% to 2,043,500 units (SEC Form 4)
- President and CEO Hwang Kuk Hyoun acquired 10,698,604 shares (SEC Form 4)